Institute For Transfusion Medicine Inc is categorized under Health Services in Glenview, IL and active since 2009.
Institute For Transfusion Medicine Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact James Covert at the company’s single location by writing to 1205 Milwaukee Avenue, Glenview, Illinois IL 60025 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Institute For Transfusion Medicine Inc |
| Contact Person: | James Covert |
| Address: | 1205 Milwaukee Avenue, Glenview, Illinois 60025 |
| Website Address: | itxm.org |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Institute For Transfusion Medicine Inc was started in 2009 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact James Covert for inquiries that concern Institute For Transfusion Medicine Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Institute For Transfusion Medicine Inc can be found at the coordinates as well as the street address 1205 Milwaukee Avenue in Glenview, Illinois 60025.
For its online presence, you may visit Institute For Transfusion Medicine Inc’s website at itxm.org and engage with its social media outlets through on Twitter and on Facebook.